Position in VRTX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$12,554,850
+$1,369,470 QoQ
Shares Held
25,275
+0.9% QoQ
Ownership
0.010%
of shares outstanding
% of Portfolio
0.19%
of 13F equity value
Holder Rank
#330
of 1,735 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in VRTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Norinchukin Bank, The holds $23,476,207 across 6 Biotechnology names. VRTX ranks #1 (53.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
This page
|
25,275 | $12,554,850 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
9,834 | $6,131,892 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
5,171 | $1,556,626 | |
| 4 | MRNA |
Moderna, Inc.
|
21,383 | $1,497,451 | |
| 5 | INCY |
Incyte Corp
|
9,401 | $1,065,697 | |
| 6 | TECH |
BIO-TECHNE Corp
|
9,479 | $669,691 |
All Filings in VRTX
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $12,554,850 | 25,275 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $11,185,380 | 25,049 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $10,972,672 | 24,203 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $8,626,262 | 22,026 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $9,765,907 | 21,936 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $9,733,731 | 20,077 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $5,620,483 | 13,957 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $5,976,743 | 12,851 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $5,219,197 | 11,135 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $4,652,451 | 11,130 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $4,625,118 | 11,367 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $4,529,661 | 13,026 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $9,441,393 | 26,829 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $6,366,619 | 20,207 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $5,684,634 | 19,685 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $6,970,965 | 24,076 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $6,097,372 | 21,638 | Shares | Defined | 2022-08-10 | |
| 2022-03-31 | $6,878,386 | 26,357 | Shares | Defined | 2022-05-12 | |
| 2021-12-31 | $5,242,950 | 23,875 | Shares | Defined | 2022-02-10 | |
| 2021-09-30 | $4,678,773 | 25,794 | Shares | Defined | 2021-11-09 | |
| 2021-06-30 | $4,918,763 | 24,395 | Shares | Defined | 2021-08-11 | |
| 2021-03-31 | $5,195,610 | 24,178 | Shares | Defined | 2021-05-12 | |
| 2020-12-31 | $5,445,982 | 23,043 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $6,306,381 | 23,175 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $6,502,073 | 22,397 | Shares | Defined | 2020-08-12 | |
| 2020-03-31 | $5,327,224 | 22,388 | Shares | Defined | 2020-05-13 | |
| No filing history on record for this holder in this stock. | ||||||